JP2006503033A5 - - Google Patents

Download PDF

Info

Publication number
JP2006503033A5
JP2006503033A5 JP2004536098A JP2004536098A JP2006503033A5 JP 2006503033 A5 JP2006503033 A5 JP 2006503033A5 JP 2004536098 A JP2004536098 A JP 2004536098A JP 2004536098 A JP2004536098 A JP 2004536098A JP 2006503033 A5 JP2006503033 A5 JP 2006503033A5
Authority
JP
Japan
Prior art keywords
dihydro
benzimidazol
anilino
cyclohexylmethyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004536098A
Other languages
English (en)
Japanese (ja)
Other versions
JP4551765B2 (ja
JP2006503033A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/027692 external-priority patent/WO2004024699A1/en
Publication of JP2006503033A publication Critical patent/JP2006503033A/ja
Publication of JP2006503033A5 publication Critical patent/JP2006503033A5/ja
Application granted granted Critical
Publication of JP4551765B2 publication Critical patent/JP4551765B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004536098A 2002-09-13 2003-09-04 ベンズイミダゾロン及びサイトカイン抑制剤としてのそれらの使用 Expired - Lifetime JP4551765B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41042002P 2002-09-13 2002-09-13
PCT/US2003/027692 WO2004024699A1 (en) 2002-09-13 2003-09-04 Benzimidazolones and their use as cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2006503033A JP2006503033A (ja) 2006-01-26
JP2006503033A5 true JP2006503033A5 (enExample) 2006-10-19
JP4551765B2 JP4551765B2 (ja) 2010-09-29

Family

ID=31994134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004536098A Expired - Lifetime JP4551765B2 (ja) 2002-09-13 2003-09-04 ベンズイミダゾロン及びサイトカイン抑制剤としてのそれらの使用

Country Status (9)

Country Link
US (1) US7115644B2 (enExample)
EP (1) EP1539708B1 (enExample)
JP (1) JP4551765B2 (enExample)
AT (1) ATE382039T1 (enExample)
AU (1) AU2003265924A1 (enExample)
CA (1) CA2498754C (enExample)
DE (1) DE60318320T2 (enExample)
ES (1) ES2297265T3 (enExample)
WO (1) WO2004024699A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023761A2 (en) * 2003-09-11 2005-03-17 Kemia, Inc. Cytokine inhibitors
WO2007015877A2 (en) * 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
WO2011021678A1 (ja) * 2009-08-21 2011-02-24 武田薬品工業株式会社 縮合複素環化合物
BR112014030940B1 (pt) * 2012-06-11 2022-09-06 UCB Biopharma SRL Benzimidazóis que modulam tnf-alfa e composição farmacêutica compreendendo os mesmos
US8901304B1 (en) 2013-11-05 2014-12-02 King Fahd University Of Petroleum And Minerals Benzo[D]imidazole derivatives of piperidine and piperazine
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN109563051B (zh) * 2016-08-22 2024-06-11 南京明德新药研发有限公司 作为pde4抑制剂的并环类化合物
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
GB201820165D0 (en) * 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW203049B (enExample) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US5281714A (en) 1990-08-16 1994-01-25 American Home Products Corporation N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase
US5200422A (en) 1990-09-24 1993-04-06 Neurosearch A/S Benzimidazole derivatives, their preparation and use
TW284688B (enExample) 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
US5354865A (en) 1992-09-10 1994-10-11 Abbott Laboratories Phenylmethyl derivatives having lipoxygenase inhibitory activity
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
US6300325B1 (en) * 1997-01-23 2001-10-09 Smithkline Beecham Corporation IL-8 receptor antagonists
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
DE19907813A1 (de) 1999-02-24 2000-08-31 Boehringer Ingelheim Pharma Substituierte bicyclische Heterocyclen, deren Herstellung und deren Verwendung als Arzneimittel
JP2000344757A (ja) 1999-03-18 2000-12-12 Clariant Internatl Ltd チアジン−インジゴ化合物およびその新規中間体の製造方法
IL147309A0 (en) 1999-07-21 2002-08-14 Fujisawa Pharmaceutical Co Benzimidazolone derivatives and pharmaceutical compositions containg the same

Similar Documents

Publication Publication Date Title
US9404081B2 (en) Pyruvate kinase activators for use in therapy
JP2019525941A5 (enExample)
JP5221453B2 (ja) イミダゾール誘導体
US6924302B2 (en) Substituted triazole diamine derivatives as kinase inhibitors
JP2023503052A5 (enExample)
RU2011127402A (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
JP2019077725A5 (enExample)
EP2805940A1 (en) Pyrazine carboxamide compound
JP2007523905A5 (enExample)
JP5287730B2 (ja) フェニルアセトアミド誘導体
JP2006503033A5 (enExample)
CN1960731A (zh) 调节炎性和转移过程的方法
RU2011127232A (ru) Апоптоз-индуцирующие средства для лечения рака и иммунных и аутоиммунных заболеваний
JP2007509118A5 (enExample)
RU2007100136A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
JP2004507461A5 (enExample)
JP2010513458A (ja) H−pgdsの阻害剤としてのニコチンアミド誘導体、およびプロスタグランジンd2の仲介による疾患を治療するためのその使用
CA2454703A1 (en) Novel thiophene carboxamide derivatives
JP2006513261A5 (enExample)
JP2018530591A5 (enExample)
EA020887B1 (ru) Триазолсодержащие производные оксадиазола
JP2007519695A5 (enExample)
RU2016112952A (ru) Производные индола и индазола
JP2014513122A5 (enExample)
BG65456B1 (bg) Пиперазин хинолинметил бензамиди, фармацевтичен състав, който ги съдържа, и тяхното използване католекарствени средства